Genetic alterations in gliomas
- 1 January 1995
- journal article
- review article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 24 (1) , 37-38
- https://doi.org/10.1007/bf01052656
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.1994
- CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines.1994
- Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.1994
- Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2.1994
- Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification.1994
- A common region of homozygous deletion in malignant human gliomas lies between the IFN alpha/omega gene cluster and the D9S171 locus.1994
- Gene and chromosomal alterations associated with the development of human gliomasThe FASEB Journal, 1993
- Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.1993
- Histological Typing of Tumours of the Central Nervous SystemPublished by Springer Nature ,1993
- Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas.Proceedings of the National Academy of Sciences, 1990